Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The dysregulation of monocyte subpopulations in individuals at risk of developing rheumatoid arthritis

K. Prajzlerová, O. Kryštůfková, M. Komarc, H. Mann, H. Hulejová, N. Petrovská, M. Gregová, P. Hánová, K. Pavelka, J. Vencovský, L. Šenolt, M. Filková

. 2021 ; 60 (4) : 1823-1831. [pub] 20210406

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Grant support
NV17-32612A MZ0 CEP Register

OBJECTIVES: Individuals carrying antibodies against citrullinated proteins (ACPA) are at high risk of developing RA. EULAR provided a clinical definition of individuals with arthralgia suspicious for progression to RA (clinically suspect arthralgia, CSA). The alteration of monocyte subpopulations in patients with established RA has been previously described. We analysed peripheral blood monocyte subpopulations in individuals with arthralgia at risk of RA. METHODS: We included 70 at-risk individuals, defined as having arthralgia without arthritis and being either ACPA+ or meeting the clinical CSA definition, 23 patients with early RA (ERA) and 19 healthy controls (HCs). Monocytes classified as classical (CD14++CD16-), intermediate (CD14++CD16+/++) and nonclassical (CD14-/+CD16++) were analysed by flow cytometry. RESULTS: Of the 70 at-risk individuals, 46 were ACPA+ and 45 met the CSA definition. The at-risk individuals and, especially, ERA patients had a lower percentage of classical monocytes and a higher percentage of nonclassical monocytes than the HCs. ACPA positivity had no effect on the difference in the distribution of the monocyte subsets between at-risk individuals and ERA patients, but a difference was determined in those reaching the ERA phase. However, when compared with HCs, the shift of monocyte subsets was more significant in ACPA+ than in ACPA- individuals with arthralgia. This trend was observed in individuals who did not meet the CSA definition. This finding was, however, determined by a selection bias, as these individuals were solely ACPA+. CONCLUSION: The shift from classical to nonclassical monocyte subpopulations was observed already in individuals at risk of developing RA.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018865
003      
CZ-PrNML
005      
20210914145618.0
007      
ta
008      
210728s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/rheumatology/keaa518 $2 doi
035    __
$a (PubMed)33119082
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Prajzlerová, Klára $u Department of Experimental Rheumatology, Institute of Rheumatology, Prague, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
245    14
$a The dysregulation of monocyte subpopulations in individuals at risk of developing rheumatoid arthritis / $c K. Prajzlerová, O. Kryštůfková, M. Komarc, H. Mann, H. Hulejová, N. Petrovská, M. Gregová, P. Hánová, K. Pavelka, J. Vencovský, L. Šenolt, M. Filková
520    9_
$a OBJECTIVES: Individuals carrying antibodies against citrullinated proteins (ACPA) are at high risk of developing RA. EULAR provided a clinical definition of individuals with arthralgia suspicious for progression to RA (clinically suspect arthralgia, CSA). The alteration of monocyte subpopulations in patients with established RA has been previously described. We analysed peripheral blood monocyte subpopulations in individuals with arthralgia at risk of RA. METHODS: We included 70 at-risk individuals, defined as having arthralgia without arthritis and being either ACPA+ or meeting the clinical CSA definition, 23 patients with early RA (ERA) and 19 healthy controls (HCs). Monocytes classified as classical (CD14++CD16-), intermediate (CD14++CD16+/++) and nonclassical (CD14-/+CD16++) were analysed by flow cytometry. RESULTS: Of the 70 at-risk individuals, 46 were ACPA+ and 45 met the CSA definition. The at-risk individuals and, especially, ERA patients had a lower percentage of classical monocytes and a higher percentage of nonclassical monocytes than the HCs. ACPA positivity had no effect on the difference in the distribution of the monocyte subsets between at-risk individuals and ERA patients, but a difference was determined in those reaching the ERA phase. However, when compared with HCs, the shift of monocyte subsets was more significant in ACPA+ than in ACPA- individuals with arthralgia. This trend was observed in individuals who did not meet the CSA definition. This finding was, however, determined by a selection bias, as these individuals were solely ACPA+. CONCLUSION: The shift from classical to nonclassical monocyte subpopulations was observed already in individuals at risk of developing RA.
650    _2
$a dospělí $7 D000328
650    _2
$a protilátky proti citrulinovaným peptidům $x krev $7 D000075422
650    _2
$a artralgie $x etiologie $7 D018771
650    _2
$a revmatoidní artritida $x krev $x diagnóza $7 D001172
650    _2
$a C-reaktivní protein $x analýza $7 D002097
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a monocyty $x metabolismus $7 D009000
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kryštůfková, Olga $u Department of Experimental Rheumatology, Institute of Rheumatology, Prague, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Komarc, Martin $u Department of Methodology, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic
700    1_
$a Mann, Heřman $u Department of Experimental Rheumatology, Institute of Rheumatology, Prague, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hulejová, Hana $u Department of Experimental Rheumatology, Institute of Rheumatology, Prague, Czech Republic
700    1_
$a Petrovská, Nora $u Department of Experimental Rheumatology, Institute of Rheumatology, Prague, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic $7 xx0264033
700    1_
$a Gregová, Monika $u Department of Experimental Rheumatology, Institute of Rheumatology, Prague, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hánová, Petra $u Department of Experimental Rheumatology, Institute of Rheumatology, Prague, Czech Republic
700    1_
$a Pavelka, Karel $u Department of Experimental Rheumatology, Institute of Rheumatology, Prague, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Vencovský, Jiří $u Department of Experimental Rheumatology, Institute of Rheumatology, Prague, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Šenolt, Ladislav $u Department of Experimental Rheumatology, Institute of Rheumatology, Prague, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Filková, Mária $u Department of Experimental Rheumatology, Institute of Rheumatology, Prague, Czech Republic $u Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00011379 $t Rheumatology (Oxford, England) $x 1462-0332 $g Roč. 60, č. 4 (2021), s. 1823-1831
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33119082 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210914145614 $b ABA008
999    __
$a ok $b bmc $g 1689834 $s 1139311
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 60 $c 4 $d 1823-1831 $e 20210406 $i 1462-0332 $m Rheumatology $n Rheumatology (Oxford) $x MED00011379
GRA    __
$a NV17-32612A $p MZ0
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...